Matt Davis

Company: Gritstone bio

Job title: Senior Director, Molecular Biology and Sequencing

Seminars:

Individualized Immunotherapy: ctDNA Monitoring Provides Real-time Signal of Clinical Benefit in Cancer Patients 9:15 am

• A comprehensive ctDNA monitoring assay (tumor-informed and naïve design) was developed and deployed for parallel evaluation of neoantigen dynamics, tumor evolution and molecular response (MR) in phase 1/2 clinical trials of Gritstone’s individualized immunotherapy for solid tumors (GRANITE) • In an end-stage MSS-CRC patient cohort, MR was associated with extended overall survival • GRANITE…Read more

day: Day Two